Board of directors

Ron Cohen

Ron Cohen

Born: 1956
Education: B.A. with honors in Psychology from Princeton University, M.D. from the Columbia College of Physicians & Surgeons, residency in Internal Medicine at the University of Virginia Medical Center, Board Certified in Internal Medicine
Main occupation: President and Chief Executive Officer of Acorda Therapeutics, Inc.

Board membership began: Chairman of the Board since May 2016
Employment history: Acorda’s President and Chief Executive Officer since he founded Acorda in 1995; prior to this, principal in the startup of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human organ tissues for transplantation
Key positions of trust: Member of the Board of Directors of VBL Therapeutics; Chairman of the Board of the Biotechnology Innovation Organization (BIO); member of the Columbia-Presbyterian Health Sciences Advisory Council
Assessment of independence: Independent of the company, dependent of significant shareholder

Andrew A. Hindman

Andrew A. Hindman

Born: 1972
Education: B.A. from Wesleyan University graduating Phi Beta Kappa, and executive MBA from Columbia University and the University of California Berkeley, Haas School of Business.
Main occupation: Chief Business Development Officer and Head, Financial Planning and Analysis & Investor Relations of Acorda Therapeutics, Inc.

Board membership began: Board member since December 2016
Employment history:  Acorda’s Chief Business Development Officer since May 2014; prior to that, President, Chief Executive Officer and member of the Board of Tobira Therapeutics. Previously held senior corporate development and commercial operating positions at Nodality, Onyx Pharmaceuticals and Gilead Sciences.  
Key positions of trust:  Leadership team of Acorda Therapeutics, Inc.
Assessment of independence:  Independent of the company, dependent of significant shareholder

Jane Wasman

Jane Wasman

Born: 1956
Education: Magna Cum Laude and Phi Beta Kappa from Princeton University, J.D. from Harvard Law School
Main occupation: President, International, General Counsel and Corporate Secretary of Acorda Therapeutics, Inc.

Board membership began: Board member since May 2016
Employment history: Acorda’s President, International, General Counsel and Corporate Secretary since October 2012; prior to that, senior positions in Acorda since 2004 and various leadership positions at Schering Plough Corporation from 1995 to 2004
Key positions of trust: Member of the Board of Directors and the Executive Committee of the Board of the New York Biotechnology Association (NYBA)
Assessment of independence: Independent of the company, dependent of significant shareholder

Updated 23 December, 2016